Quotes 5-day view Delayed Nasdaq
Estimated financial data (e) (USD)
Net income 2021
Net Debt 2021
P/E ratio 2021
Net income 2022
Net Debt 2022
P/E ratio 2022
2 894 M
2 894 M
Capi. / Sales 2021
Capi. / Sales 2022
Nbr of Employees
Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. The Company's...
Ratings of Fulgent Genetics, Inc.
All news about FULGENT GENETICS, INC.
11/09 FULGENT GENETICS, INC. Management's Discussion and Analysis of Financial Condition and..
11/09 Fulgent Genetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months E..
11/09 Fulgent Genetics Reports Third Quarter Financial Results - Form 8-K
11/09 Fulgent Genetics Seeks M&A
11/09 Fulgent Genetics Reports Higher Q3 Non-GAAP EPS as Revenue More Than Doubles, Lifts 202..
11/09 FULGENT GENETICS, INC. : Results of Operations and Financial Condition, Regulation FD Disc..
11/09 Fulgent Genetics Reports Third Quarter Financial Results
11/09 Earnings Flash (FLGT) FULGENT GENETICS Reports Q3 Revenue $227.9M, vs. Street Est of $2..
11/09 Earnings Flash (FLGT) FULGENT GENETICS Reports Q3 EPS $4.05, vs. Street Est of $3.25
11/09 Fulgent Genetics, Inc. Revises Earnings Guidance for the Full Year 2021
11/09 Fulgent Genetics, Inc. Provides Revenue Guidance for the Fourth Quarter of 2021
11/09 EARNINGS REACTION HISTORY : Fulgent Genetics Inc, 55.6% Follow-Through Indicator, 16.7% Se..
11/09 Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences
11/08 Helio Health Inc. and Fulgent Genetics, Inc. Announce New Positive Performance Data of ..
11/04 Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteo..
News in other languages on FULGENT GENETICS, INC.
Analyst Recommendations on FULGENT GENETICS, INC.
Chart FULGENT GENETICS, INC.
Technical analysis trends FULGENT GENETICS, INC.
Short Term Mid-Term Long Term Trends Neutral Neutral Neutral
Number of Analysts
Last Close Price
Average target price
Spread / Average Target